The Asp298 but not the C-786 genotype of the endothelial nitric oxide synthase is reduced with age in healthy Swiss men

References

1. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–6. 10.1038/327524a0Search in Google Scholar

2. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057–8. 10.1016/S0140-6736(87)91481-4Search in Google Scholar

3. Barbato JE, Tzeng E. Nitric oxide and arterial disease. J Vasc Surg 2004; 40: 187–93. 10.1016/j.jvs.2004.03.043Search in Google Scholar

4. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786→C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864–70. 10.1161/01.CIR.99.22.2864Search in Google Scholar

5. Wang XL, Sim AS, Wang MX, Trudinger B, Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 2000; 471: 45–50. 10.1016/S0014-5793(00)01356-9Search in Google Scholar

6. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000; 97: 2832–5. 10.1073/pnas.97.6.2832Search in Google Scholar PubMed PubMed Central

7. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)→Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 2001; 276: 26674–9. 10.1074/jbc.M103647200Search in Google Scholar PubMed

8. McDonald DM, Alp NJ, Channon KM. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 2004; 14: 831–9. 10.1097/00008571-200412000-00006Search in Google Scholar PubMed

9. Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 2004; 109: 1359–65. 10.1161/01.CIR.0000121357.76910.A3Search in Google Scholar PubMed

10. Morris BJ, Zee RY, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994; 94: 1085–9. 10.1172/JCI117423Search in Google Scholar PubMed PubMed Central

11. Hersberger M, Marti-Jaun J, Rentsch K, Hanseler E. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin Chem 2000; 46: 1072–7. 10.1093/clinchem/46.8.1072Search in Google Scholar

12. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A, et al. Polymorphisms of the endothelial nitric oxide synthase gene – no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 1999; 29: 284–90. 10.1046/j.1365-2362.1999.00451.xSearch in Google Scholar

13. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89: 6348–52. 10.1073/pnas.89.14.6348Search in Google Scholar

14. D'Agostino RB, Kannel WB, Belanger AJ, Sytkowski PA. Trends in CHD and risk factors at age 55–64 in the Framingham Study. Int J Epidemiol 1989; 18: S67–S72. 10.1093/ije/18.Supplement_1.S67Search in Google Scholar

15. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383–90. 10.1016/0002-8703(86)90155-9Search in Google Scholar